Clinical Trials Browser

Phase 2 × Active not recruiting × Malignant Solid Tumor × Clear all

NCT03694249 2024-06-27

Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence

Phase 2 Active not recruiting

Other solid neoplasm

Malignant Solid Tumor